ALPN
Alpine Immune Sciences, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website alpineimmunesciences.com
- Employees(FY) 126
- ISIN US02083G1004
Performance
+0.23%
1W
+0.73%
1M
+107.84%
3M
+413.19%
6M
+240.87%
YTD
+657.23%
1Y
Profile
Alpine Immune Sciences, Inc. operates as a clinical-stage immunotherapy company. It focuses on creating various immunotherapies through protein engineering technologies for autoimmune and inflammatory diseases. The company has strategic collaborations with biopharmaceutical companies and has a pipeline of clinical and preclinical candidates in development. Its pipeline includes Povetacicept, a dual B cell cytokine antagonist for multiple autoimmune and inflammatory diseases; and Acazicolcept, a dual inhibitor of the CD28 and ICOS T cell costimulatory pathways for treatment of severe inflammatory diseases. Alpine Immune Sciences, Inc. was incorporated in 2007 and is headquartered in Seattle, Washington.
Investment Analysis Report: ALPN
Overview
ALPN is a company operating in the Health Technology sector, specifically in the Biotechnology industry. The company has a market capitalization of $2.05 billion. In this report, we will conduct a comprehensive analysis of ALPN's financial statements over the past three years, including the balance sheet...
Technical Analysis of ALPN 2024-05-10
Overview:
In analyzing the technical indicators for ALPN over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions to guide investme...
Recent News & Updates
- 2024-05-10 15:32
- 2024-05-10 12:46
- 2024-05-09 16:00
- 2024-05-09 10:56
- 2024-05-09 04:00
- 2024-05-07 11:24
- 2024-05-07 09:50
Q1 2024 Vertex Pharmaceuticals Inc Earnings Call(Thomson Reuters StreetEvents)
- 2024-05-07 03:08
- 2024-05-06 23:24
- 2024-05-06 20:45
- 2024-05-02 20:45
3 Growth Stocks You'll Kick Yourself for Not Buying Today(Investorplace)
- 2024-05-02 10:01
- 2024-05-01 22:01
- 2024-04-24 23:28
11 Oversold MidCap Stocks To Buy Now(Insidermonkey)
- 2024-04-17 20:30
- 2024-04-15 15:43
- 2024-04-14 21:15
- 2024-04-13 05:29
Could This Stock Be the Next Biotech Buyout?(Motley Fool)
- 2024-04-12 12:36
- 2024-04-12 10:55
Health Care Roundup: Market Talk(The Wall Street Journal)
- 2024-04-12 00:36
- 2024-04-11 16:43
- 2024-04-11 16:29
Vertex Pharmaceuticals to buy Alpine Immune Sciences in $4.9B deal(Yahoo Finance Video)
- 2024-04-11 13:59
Stocks to Watch Thursday: Robinhood, Alpine Immune, Constellation Brands(The Wall Street Journal)
- 2024-04-11 11:03
- 2024-04-11 10:36
Alpine Catapults 37% After Vertex Pledges $4.9 Billion To Buy It(Investor's Business Daily)
- 2024-04-11 09:39
- 2024-04-11 06:10
These Stocks Are Moving the Most Today(Barrons.com)
- 2024-04-11 06:10
- 2024-04-10 23:58
Page 1 of 6
previousnext